Coronavirus membrane fusion mechanism offers as a potential target for antiviral development. Antiviral Res • April 10, 2020
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res • April 7, 2020
The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res • April 7, 2020
Emergence of oseltamivir-resistant influenza A H1N1 virus during the 2007-2008 winter season in Luxembourg: clinical characteristics and epidemiology. Antiviral Res • November 12, 2009